Departed
Gary Kiss
director
BRGX ·
BIOREGENX, INC.
On April 4, 2025, Gary Kiss resigned from his position as director of BioRegenx, Inc., effective immediately.
Ready 8-Ks
10
Latest filing
April 14, 2025, 7:59 PM ET
Top materiality
0.90
Event mix
leadership ×5 · m_and_a ×3 · other_material ×2
Sentiment
0 pos · 4 neg · 6 neu
Executive change
recent →
Recent 8-K filings for BRGX
Highest-materiality recent filing
BioRegenx completes reverse merger with Findit; new board, name change effective March 8, 2024
- BioRegenx merged into Findit (OTC Pink: FDIT); surviving entity renamed BioRegenx, Inc.
- Former BioRegenx holders received 851,977,296 common + 3,800 Series A preferred shares, representing 90% voting control.
-
BioRegenx directors Gary Hennerberg and Gary Kiss resign
Gary Hennerberg resigned as director effective April 7, 2025.
-
Director Robert Doran resigns from BioRegenx board effective Jan 31, 2025
Robert Doran submitted resignation as director on Jan 15, effective Jan 31, 2025.
-
BioRegenx appoints Richard Janney to board; forms audit committee
Richard Janney appointed to BioRegenx board effective October 7, 2024, until successor elected or removed.
-
BioRegenx completes reverse merger; posts $3.6M net loss in 2023 with going concern doubt
Merger effective March 8, 2024: BioRegenx merged into Findit; registrant renamed BioRegenx, Inc.
-
BioRegenx officer and director Sherri Adams resigns effective July 17, 2024
Sherri Adams resigned as officer and director effective July 17, 2024, to pursue other business interests.
-
Director Jody M. Walker resigns from BioRegenx board effective July 13, 2024
Walker resigned as director due to retirement, effective July 13, 2024.
-
BioRegenx restates Q1 2024 financials; appoints Weinberg & Co. as new auditor
Engaged Weinberg & Company as new independent accountant for fiscal years ended Dec 31, 2023 and 2022, effective June 10, 2024.
-
BioRegenx dismisses BF Borgers as auditor; BF Borgers barred from SEC practice
On May 15, 2024, BioRegenx dismissed BF Borgers CPA PC as its independent registered public accounting firm, approved by audit committee.
-
BioRegenx completes reverse merger with Findit; new board, name change effective March 8, 2024
BioRegenx merged into Findit (OTC Pink: FDIT); surviving entity renamed BioRegenx, Inc.
-
Findit enters definitive merger with BioRegenx; existing shareholders to hold 10% of voting stock
BioRegenx shareholders will receive common and preferred shares equivalent to 90% of Findit's voting securities.
Executive changes
Departed
Gary Hennerberg
director
BRGX ·
BIOREGENX, INC.
On April 7, 2025, Gary Hennerberg resigned from his position as director of BioRegenx, Inc., effective immediately.
Departed
Robert Doran
director
BRGX ·
BIOREGENX, INC.
On January 15, 2025, Robert Doran submitted his resignation from his position as director of BioRegenx, Inc., which shall be effective January 31, 2025.
Appointed
Richard Janney
Director
BRGX ·
BIOREGENX, INC.
On October 7, 2024, BioRegenx, Inc., a Nevada corporation (“BioRegenx”) appointed Richard Janney to serve as a member of its board of directors until his successor is elected and qualified, or until he resigns or is removed.
Appointed
Gary Hennerberg
Director
BRGX ·
BIOREGENX, INC.
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
Appointed
Gary Hennerberg
Secretary
BRGX ·
BIOREGENX, INC.
Gary Hennerberg – Secretary
Appointed
Jody Walker
Director
BRGX ·
BIOREGENX, INC.
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
Appointed
Robert Doran
Executive Vice President
BRGX ·
BIOREGENX, INC.
Robert Doran – Executive Vice President
Appointed
Sherri Adams
Director
BRGX ·
BIOREGENX, INC.
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
Appointed
Sherri Adams
Chief Operating Officer
BRGX ·
BIOREGENX, INC.
Sherri Adams – Chief Operating Officer
Appointed
Robert Doran
Director
BRGX ·
BIOREGENX, INC.
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
Departed
Thomas Powers
Other Named Officer
BRGX ·
BIOREGENX, INC.
Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant
Materiality & sentiment trend
Max materiality 0.90 · Median 0.57 · Most common event leadership